FDA approves new weight loss pill in record time
A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most drugs in recent years.
Apr 2, 2026
0
8
Weight management news
GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious ...
Jun 6, 2026
0
8
ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
8
Why drinking alcohol may make you reach for chips and pizza
Drinking alcohol may lead people to overconsume savory ultra-processed foods, according to new research from the University of Sydney's Charles Perkins Centre, with researchers suggesting this may contribute to excess energy ...
Jun 3, 2026
0
8
Link between parents' and children's weight is mostly genetic, study finds
The association between parents' body mass index (BMI) and their children's childhood BMI may be primarily due to genetic inheritance rather than any direct biological effect of parental weight during pregnancy, according ...
Jun 23, 2026
0
8
Could one shot replace weekly GLP-1 drugs? DNA approach shows months-long effects in mice
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instruction can produce weight loss and blood glucose control in murine models that lasts up to 10 times as long ...
Jun 29, 2026
0
8
New weight loss pill gets approval, but FDA seeks more safety data
The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, according to an approval letter released Tuesday.
Apr 15, 2026
0
8
Severe obesity may weaken heart muscle in common heart failure, but weight loss could help
In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type of heart failure experience weakened heart muscles, and that losing weight may reverse some of ...
Apr 23, 2026
0
8
Type 2 diabetes risk found to vary widely among adults 18–40 with prediabetes
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing type 2 diabetes, according to ...
Mar 17, 2026
0
8
Study shows benefits in obesity-linked conditions of losing more weight with GLP-1 treatment
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less ...
May 9, 2026
0
8
